Polymorphisms in OX40/OX40L associated with enhanced protein expression have been described to be associated with SLE [56, 57] and human monosomy 1q36 evidences activated CD4+ T-cell sustainment via OX40 [58]. Here, TNFRSF4 is linked to systemic lupus erythematosus.